Q4 2022 · —
Revenue—
Net Income-$2.92M-$2.92M N/M vs Q4 2021N/M vs Q1 2022
EPS Diluted-$0.06-$0.06 N/M vs Q4 2021N/M vs Q1 2022
Operating Income-$2,963,243N/M
Operating Cash Flow-$3,177,413N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q4 2022 | Q4 2021 | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$2.92M | -$3.39M | -$2.99M | -$1.98M |
| EPS Diluted | -$0.06 | -$0.07 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR